A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK

Ejemplares similares

• Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
  por: McLornan, DP, et al.
  Publicado: (2023)
• Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
  por: Reilly, J, et al.
  Publicado: (2014)
• Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
  por: Reilly, J, et al.
  Publicado: (2014)
• A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
  por: McMullin, M, et al.
  Publicado: (2018)
• Guideline for the diagnosis and management of myelofibrosis
  por: Reilly, J, et al.
  Publicado: (2012)